title: [Vulvovaginal candidiasis].
abstract: Vulvovaginal candidiasis is the second most common vaginal infection after bacterial vaginosis. It is caused by yeasts, the vast majority of which belong to the genus Candida. Vulvovaginal candidiasis affects as many as 75 % of women during their childbearing years and 40 % of them experience recurrences. The most common etiological agent is Candida albicans, which is responsible for nearly 90 % of cases. Vulvovaginal candidiasis can be treated with topical and/or systemic antifungals while risk factors for the infection must be eliminated.
authors.affiliation: Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University in Olomouc, Czech Republic, e-mail: luciettasv@seznam.cz.
authors.forename: Lucie
authors.initials: L
authors.lastname: Svobodová
authors.forename: Pavlína
authors.initials: P
authors.lastname: Lysková
authors.forename: Petr
authors.initials: P
authors.lastname: Hamal
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use*; D002176:Candida albicans / Q000502:physiology*; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D005260:Female; D006801:Humans; D012008:Recurrence; D012307:Risk Factors
chemical_list: D000935:Antifungal Agents